Less exercise, more time spent in front of screens, higher psychological stress, and reduced physical fitness: These alarming results were obtained by various studies focusing on children and adolescents during the Covid-19 pandemic.
Awakn Selects Eurofins Discovery for Pharmacology Testing in New Chemical Entity (NCE) Pre-Clinical Program | Psychedelic Invest
Toronto, Ontario–(Newsfile Corp. – October 4, 2024) – Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”), a clinical-stage biotechnology
October 4, 2024